Published in Vaccine Weekly, February 26th, 1996
Currently there are at least 76 types of human papillomaviruses (HPVs). Approximately 40 of them are known to infect the human reproductive tract. Ninety percent of cervical neoplasms in women are a result of HPV infection and a prophylactic vaccine has the potential to reduce mortality and morbidity from this disease.
Because there are so many HPV types, it is extremely challenging to produce a single prophylactic vaccine with the potential to protect against all or most of them. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.